Business Description
China Traditional Chinese Medicine Holdings Co Ltd
ISIN : HK0000056256
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 3.63 | |||||
Interest Coverage | 6.83 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.18 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.1 | |||||
3-Year EBITDA Growth Rate | -9.3 | |||||
3-Year EPS without NRI Growth Rate | -11.4 | |||||
3-Year Book Growth Rate | 2.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.12 | |||||
Quick Ratio | 1.48 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 244.11 | |||||
Days Sales Outstanding | 183.26 | |||||
Days Payable | 97.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.19 | |||||
3-Year Dividend Growth Rate | -0.6 | |||||
Shareholder Yield % | 2.69 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.18 | |||||
Operating Margin % | 7.5 | |||||
Net Margin % | 7.09 | |||||
FCF Margin % | 3.77 | |||||
ROE % | 6.19 | |||||
ROA % | 3.45 | |||||
ROIC % | 5.5 | |||||
ROC (Joel Greenblatt) % | 8.16 | |||||
ROCE % | 5.25 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.3 | |||||
PE Ratio without NRI | 15.3 | |||||
Shiller PE Ratio | 13.32 | |||||
Price-to-Owner-Earnings | 36.81 | |||||
PS Ratio | 1.08 | |||||
PB Ratio | 0.93 | |||||
Price-to-Tangible-Book | 1.59 | |||||
Price-to-Free-Cash-Flow | 28.85 | |||||
Price-to-Operating-Cash-Flow | 16.81 | |||||
EV-to-EBIT | 14.8 | |||||
EV-to-Forward-EBIT | 11.77 | |||||
EV-to-EBITDA | 14.8 | |||||
EV-to-Forward-EBITDA | 7.82 | |||||
EV-to-Revenue | 1.16 | |||||
EV-to-Forward-Revenue | 1.07 | |||||
EV-to-FCF | 30.96 | |||||
Price-to-Projected-FCF | 1.06 | |||||
Price-to-Median-PS-Value | 0.54 | |||||
Price-to-Graham-Number | 1.04 | |||||
Price-to-Net-Current-Asset-Value | 4.77 | |||||
Earnings Yield (Greenblatt) % | 6.76 | |||||
FCF Yield % | 3.46 | |||||
Forward Rate of Return (Yacktman) % | -3.75 |